These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
333 related items for PubMed ID: 28624613
21. Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France. Lemée V, Zaharia I, Nevez G, Rabodonirina M, Brasseur P, Ballet JJ, Favennec L. J Antimicrob Chemother; 2000 Nov; 46(5):819-21. PubMed ID: 11062206 [Abstract] [Full Text] [Related]
22. Treatment-ladder and genetic characterisation of parasites in refractory giardiasis after an outbreak in Norway. Mørch K, Hanevik K, Robertson LJ, Strand EA, Langeland N. J Infect; 2008 Apr; 56(4):268-73. PubMed ID: 18328567 [Abstract] [Full Text] [Related]
23. Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome. Abboud P, Lemée V, Gargala G, Brasseur P, Ballet JJ, Borsa-Lebas F, Caron F, Favennec L. Clin Infect Dis; 2001 Jun 15; 32(12):1792-4. PubMed ID: 11360222 [Abstract] [Full Text] [Related]
24. A family cluster of giardiasis with variable treatment responses: refractory giardiasis in a family after a trip to India. Requena-Méndez A, Goñi P, Lóbez S, Oliveira I, Aldasoro E, Valls ME, Clavel A, Gascón J, Muñoz J. Clin Microbiol Infect; 2014 Feb 15; 20(2):O135-8. PubMed ID: 23926944 [Abstract] [Full Text] [Related]
25. [Therapeutic results in Giardia lamblia infestation]. Martínez Costa C, García Vila A, Brines Solanes J, Codoñer Franch P. An Esp Pediatr; 1988 May 15; 28(5):425-8. PubMed ID: 3178058 [Abstract] [Full Text] [Related]
26. Refractory giardiasis in Spanish travellers. Muñoz Gutiérrez J, Aldasoro E, Requena A, Comin AM, Pinazo MJ, Bardají A, Oliveira I, Valls ME, Gascon J. Travel Med Infect Dis; 2013 May 15; 11(2):126-9. PubMed ID: 23218784 [Abstract] [Full Text] [Related]
27. Comparison of chloroquine, albendazole and tinidazole in the treatment of children with giardiasis. Escobedo AA, Núñez FA, Moreira I, Vega E, Pareja A, Almirall P. Ann Trop Med Parasitol; 2003 Jun 15; 97(4):367-71. PubMed ID: 12831522 [Abstract] [Full Text] [Related]
28. Single-dose therapy for giardiasis in school-age children. Pengsaa K, Limkittikul K, Pojjaroen-anant C, Lapphra K, Sirivichayakul C, Wisetsing P, Nantha-aree P, Chanthavanich P. Southeast Asian J Trop Med Public Health; 2002 Dec 15; 33(4):711-7. PubMed ID: 12757214 [Abstract] [Full Text] [Related]
29. A meta-analysis of the effectiveness of albendazole compared with metronidazole as treatments for infections with Giardia duodenalis. Solaymani-Mohammadi S, Genkinger JM, Loffredo CA, Singer SM. PLoS Negl Trop Dis; 2010 May 11; 4(5):e682. PubMed ID: 20485492 [Abstract] [Full Text] [Related]
30. A comparative clinical trial of albendazole versus metronidazole in giardiasis. Misra PK, Kumar A, Agarwal V, Jagota SC. Indian Pediatr; 1995 Mar 11; 32(3):291-4. PubMed ID: 8613282 [Abstract] [Full Text] [Related]
31. Giardiasis: Characteristics, Pathogenesis and New Insights About Treatment. Vivancos V, González-Alvarez I, Bermejo M, Gonzalez-Alvarez M. Curr Top Med Chem; 2018 Mar 11; 18(15):1287-1303. PubMed ID: 30277155 [Abstract] [Full Text] [Related]
32. A comparative clinical trial of albendazole versus metronidazole in children with giardiasis. Misra PK, Kumar A, Agarwal V, Jagota SC. Indian Pediatr; 1995 Jul 11; 32(7):779-82. PubMed ID: 8617554 [Abstract] [Full Text] [Related]
33. Chemotherapy in giardiasis: clinical responses and in vitro drug sensitivity of human isolates in axenic culture. McIntyre P, Boreham PF, Phillips RE, Shepherd RW. J Pediatr; 1986 Jun 11; 108(6):1005-10. PubMed ID: 3519912 [Abstract] [Full Text] [Related]
34. Evaluation of silymarin in the treatment on asymptomatic Giardia infections in dogs. Chon SK, Kim NS. Parasitol Res; 2005 Dec 11; 97(6):445-51. PubMed ID: 16151741 [Abstract] [Full Text] [Related]
35. Treatment of giardiasis. Gardner TB, Hill DR. Clin Microbiol Rev; 2001 Jan 11; 14(1):114-28. PubMed ID: 11148005 [Abstract] [Full Text] [Related]
36. Isolation, excystation and axenization of Giardia lamblia isolates: in vitro susceptibility to metronidazole and albendazole. Cruz A, Sousa MI, Azeredo Z, Leite E, Figueiredo de Sousa JC, Cabral M. J Antimicrob Chemother; 2003 Apr 11; 51(4):1017-20. PubMed ID: 12654760 [Abstract] [Full Text] [Related]
37. In vitro anti-Giardia lamblia activity of 2-aryl-3-hydroxymethyl imidazo[1,2-a]pyridines and -pyrimidines, individually and in combination with albendazole. Velázquez-Olvera S, Salgado-Zamora H, Jiménez-Cardoso E, Campos-Aldrete ME, Pérez-González C, Ben Hadda T. Acta Trop; 2016 Mar 11; 155():6-10. PubMed ID: 26657313 [Abstract] [Full Text] [Related]
38. Giardiasis, drug resistance, and new target discovery. Tian HF, Chen B, Wen JF. Infect Disord Drug Targets; 2010 Aug 11; 10(4):295-302. PubMed ID: 20429862 [Abstract] [Full Text] [Related]
39. Comparative therapeutic effect of probiotic Lactobacillus casei alone and in conjunction with antiprotozoal drugs in murine giardiasis. Shukla G, Kaur H, Sharma L. Parasitol Res; 2013 Jun 11; 112(6):2143-9. PubMed ID: 23559378 [Abstract] [Full Text] [Related]
40. Saccharomyces boulardii as therapeutic alternative in experimental giardiasis. Ribeiro MRS, Oliveira DR, Caliari MV, Cara Machado DC, Andrade MER, Cardoso VN, Dos Santos Martins F, Nicoli JR, Gomes MA. J Appl Microbiol; 2021 Jul 11; 131(1):460-469. PubMed ID: 33289232 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]